Prostate Health and Testosterone Replacement Therapy (TRT): Clinical Considerations

Tuesday, 10th September 2019

19:00 (60 mins)

Description

Through the examination of an existing evidence base, this webinar will explore the relationship between testosterone, testosterone replacement therapy, and prostate health.

Assessment of prostate health is paramount in appropriately selecting patients for testosterone replacement therapy (TRT) and is crucial to ongoing monitoring of men who are commenced on TRT.

  • Examination historical and current evidence base
  • Prostate assessment before and during TRT
  • Clinical considerations

Speakers

Dr Janine David

General Practitioner

Portway Surgery

Porthcawl, Wales, UK

Dr Janine David qualified as a GP in 2001 and specialises in Men’s and Women’s sexual health. She has been a GP partner in Portway Surgery, Porthcawl for the past 12 years. She became a GP trainer in 2005. She is secretary of the Primary Care Testosterone Advisory Group (www.PCTAG.uk) and is a member of the British, European and International Societies of Sexual Medicine (BSSM, ESSM & ISSM).

Dr David developed a special interest in Men’s and Women’s sexual health in 2013 and has since completed the Multidisciplinary Joint Committee of Sexual Medicine (MJCSM) course. She has successfully passed the associated exam which now makes her a Fellow of the European Committee of Sexual Medicine (FECSM); the highest qualification you can achieve in this field making her the only active GP in Wales to hold this qualification.

She has an interest in testosterone deficiency and testosterone therapy. She is a regular speaker, both on the national and international stage about sexual dysfunction and is actively involved in clinical research and has recently published data in the Journal of Sexual Medicine.

She is a co-author of the Men’s Health Guidelines for General Practice and has run clinical audits within her NHS practice to identify ways to improve the health of her patients in this often-overlooked area.

Dr Rowland Rees

Consultant Urologist

University Hospital Southampton

Hampshire, UK

Dr Rowland Rees is qualified in Medicine in 1995 at Barts and The London Hospital school of Medicine, taking an intercalated degree in Physiology with 1st Class Hons.

Following A&E at the Royal London, he then underwent general surgical training at St George’s and the Royal Marsden Hospitals, London, Urology training on the Wessex Urological training programme, and a sub-specialist Fellowship in Andrology & genito-urethral surgery at the Institute of Urology in London.

Following a year as locum consultant at UCLH, and 4 years as Consultant general urologist at Winchester, Dr Rees moved to University Hospital Southampton in 2013 to set up a regional Andrology service for the central south coast area of England.

Dr Rees is secretary of the BAUS section of Andrology and Genito-urethral surgery, is actively involved in the teaching and training of surgeons in the UK and abroad and is an internationally invited speaker in the field of Andrology. He has published and presented extensively in the field.

Register now

Restore the man is organised and funded by Bayer and may contain some promotional content.

Licensed for:
In the UK, Nebido® (testosterone undecanoate) is Licensed for testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

This website is intended for Healthcare Professionals resident in the UK.